Andrea Gabrio
Andrea Gabrio
Home
Blog
Research
Publications
Talks
Software
Tutorials
Missing Data
economic evaluations
Economic Evaluation of a Reablement Training Program for Homecare Staff Targeting Sedentary Behavior in Community-Dwelling Older Adults Compared to Usual Care: A Cluster Randomized Controlled Trial
Purpose: Training and supporting homecare staff in reablement aims to change staff behavior from “doing for” to “doing with” older …
TH Rooijackers
,
SF Metzelthin
,
E van Rossum
,
GIJM Kempen
,
SMAA Evers
,
A Gabrio
,
GAR Zijlstra
PDF
Cite
Project
Slides
Baseline adjustment in trial based CEA
Recently I have come across something I found a little odd when performing a statistical analysis of trial-based CEA data and I would like to share here my experience in the hope that anybody may be able to read it (and correct me if I am wrong).
Andrea Gabrio
Last updated on Oct 10, 2021
discussion
Handling missing values in individual-level cost-effectiveness analyses
Invited presentation
Jun 22, 2021
PDF
Code
Project
missingHE a Package to Handle Missing Data in Health Economic Evaluations
Invited presentation
Jun 1, 2021
PDF
Code
Project
Joint longitudinal models for dealing with missing at random data in trial-based economic evaluations
Objectives: In trial-based economic evaluation, some individuals are typically associated with missing data at some time point, so that …
A Gabrio
,
R Hunter
,
AJ Mason
,
G Baio
PDF
Cite
Project
Slides
Linear mixed models to handle missing at random data in trial-based economic evaluations
Contributed presentation
Jan 6, 2021
PDF
Code
Project
A Bayesian framework for patient-level partitioned survival cost-utility analysis
Patient-level health economic data collected alongside clinical trials are an important component of the process of technology …
A Gabrio
PDF
Project
Slides
Understanding Health Economics in Clinical Trials
Three day short course"
Nov 9, 2020
Project
Slides
Joint longitudinal models for dealing with missing at random data in trial-based economic evaluations
Health economic evaluations based on patient-level data collected alongside clinical trials (e.g. health related quality of life and …
A Gabrio
,
R Hunter
,
AJ Mason
,
G Baio
PDF
Project
Slides
Addition of abiraterone to first-line long-term hormone therapy in prostate cancer (STAMPEDE): Model to estimate long-term survival, quality-adjusted survival, and cost-effectiveness
Results from randomised trials show adding abiraterone acetate plus prednisolone (AAP) to standard of care (SOC) improves disease-free …
C Clarke C
,
C Brawley
,
F Ingleby
,
A Gabrio
,
D Dearnaley
,
D Matheson
,
G Attard
,
H Rush
,
R Jones
,
N Clarke
,
M Parmar
,
M Sydes
,
R Hunter
,
N James
PDF
Project
Slides
«
»
Cite
×